Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 1,674 | 1,590 | 1,914 | 2,209 | 1,899 |
| Operating Income | -1,674 | -1,590 | -1,914 | -2,209 | -1,899 |
| Other Income | 48 | 66 | 68 | 55 | 4 |
| Pre-tax Income | -1,626 | -1,524 | -1,846 | -2,154 | -1,895 |
| Net Income Continuous | -1,626 | -1,524 | -1,846 | -2,154 | -1,895 |
| Net Income | $-1,626 | $-1,524 | $-1,846 | $-2,154 | $-1,895 |
| EPS Basic Total Ops | -3.45 | -1.54 | -3.62 | -0.47 | 5.11 |
| EPS Basic Continuous Ops | -3.46 | -1.54 | -3.62 | -0.47 | 5.26 |
| EPS Diluted Total Ops | -3.45 | -1.54 | -3.62 | -0.47 | 5.11 |
| EPS Diluted Continuous Ops | -3.46 | -1.54 | -3.62 | -0.47 | 5.26 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -1.54 | -3.62 | -4.23 | N/A |
| EBITDA(a) | $-1,674 | $-1,590 | $-1,913 | $-2,208 | $-1,889 |